Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,153
archived clinical trials in
Gout

Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
mi
from
Perrysburgh, OH
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
mi
from
Perrysburgh, OH
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Willoughby Hills, OH
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Willoughby Hills, OH
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Norman, OK
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Jenkintown, PA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Lancaster, PA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Lansdale, PA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Lansdale, PA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Reading, PA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Reading, PA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Sellersville, PA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Sellersville, PA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Myrtle Beach, SC
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Rock Hill, SC
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Spartanburg, SC
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Brentwood, TN
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Brentwood, TN
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Spring Hill, TN
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Spring Hill, TN
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Houston, TX
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
San Antonio, TX
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Victoria, TX
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Victoria, TX
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
mi
from
South Bountiful, UT
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
mi
from
South Bountiful, UT
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
mi
from
West Jordon, UT
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
mi
from
West Jordon, UT
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
West Layton, UT
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
West Layton, UT
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Richmond, VA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Suffolk, VA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Suffolk, VA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Spokane, WA
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
Clinical Research Facility
mi
from
Morgantown, WV
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated:  1/14/2016
mi
from
Butterfield,
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects With Gout and an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor
Status: Enrolling
Updated: 1/14/2016
mi
from
Butterfield,
Click here to add this to my saved trials
CLinical Prediction Rule Score in Veterans
Development of CLinical Prediction Rule Score in Veterans: A Study of Impact of Gout on Health Care Utilization and Costs
Status: Enrolling
Updated:  3/14/2016
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
CLinical Prediction Rule Score in Veterans
Development of CLinical Prediction Rule Score in Veterans: A Study of Impact of Gout on Health Care Utilization and Costs
Status: Enrolling
Updated: 3/14/2016
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
An Open-Label, Sequential, Ascending Single-Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of an Intravenous Infusion of SEL-037 in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling
Updated:  4/15/2016
Altoona Center for Clincal Research
mi
from
Duncansville, PA
Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
An Open-Label, Sequential, Ascending Single-Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of an Intravenous Infusion of SEL-037 in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling
Updated: 4/15/2016
Altoona Center for Clincal Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
An Open-Label, Sequential, Ascending Single-Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of an Intravenous Infusion of SEL-037 in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling
Updated:  4/15/2016
Metroplex Clinical Research Center
mi
from
Dallas, TX
Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
An Open-Label, Sequential, Ascending Single-Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Study of an Intravenous Infusion of SEL-037 in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling
Updated: 4/15/2016
Metroplex Clinical Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
RDEA3170 PK/PD Study
A Phase 1, Randomized, Open-Label Study in Healthy Adult Male Subjects to Assess the Pharmacokinetics and Pharmacodynamics of RDEA3170
Status: Enrolling
Updated:  8/31/2016
Clinical Research Facility
mi
from
Austin, TX
RDEA3170 PK/PD Study
A Phase 1, Randomized, Open-Label Study in Healthy Adult Male Subjects to Assess the Pharmacokinetics and Pharmacodynamics of RDEA3170
Status: Enrolling
Updated: 8/31/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Birmingham, AL
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Gulf Shores, AL
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
mi
from
Pinson, AL
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
mi
from
Pinson, AL
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Glendale, AZ
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Mesa, AZ
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Peoria, AZ
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Little Rock, AR
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Anaheim, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Gold River, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Gold River, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Irvine, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Roseville, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Sacramento, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
San Diego, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
San Leandro, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
San Leandro, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
San Ramon, CA
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
San Ramon, CA
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Colorado Springs, CO
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Denver, CO
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Englewood, CO
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Englewood, CO
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Brandon, FL
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated:  1/23/2017
Clinical Research Facility
mi
from
Brooksville, FL
Lesinurad and Allopurinol Combination Extension Study in Gout
A Long-Term Extension Study of Lesinurad in Combination With Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol
Status: Enrolling
Updated: 1/23/2017
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials